Innoviva, Inc. (INVA)

NasdaqGS • Currently up 0.14 (+0.67%) in today's trading session

1 member of Congress has disclosed 2 trades in Innoviva, Inc. (INVA) via STOCK Act filings. The most recent disclosure was a sale by George Whitesides on 25 March 2025. Aggregate disclosed activity totals roughly $450K in sales (midpoint estimates from bracketed disclosure amounts).

Innoviva, Inc. is currently trading at $21.17, positioned at 54% of its 52-week range ($16.52 – $25.15).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$21.17
24h Change
+0.14 (+0.67%)
52 Week Range
$16.52—$25.15
View on NASDAQ

Innoviva, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for INVA

Select to highlight on chart
2 transactions
Compliance: 100%
George Whitesides25 Mar 202523 Apr 2025SaleStock$250,001 - $500,000N/A
George Whitesides24 Mar 202523 Apr 2025SaleStock$50,001 - $100,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.56B

Volume

412.69K

Beta

0.34

P/E Ratio

4.60

Fundamentals

EPS

$4.60

Div. Yield

4.72%

Open

$21.17

Day Range

$20.93 — $21.24

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Pavel Raifeld
IPO Date
2004-10-05
Website
www.inva.com

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which in...

Earnings

Next Report

Q3 2026

4 Nov

EPS Est.

$0.50

Rev. Est.

$115.4M

Days Until

70

Recent Quarters

Q2 20265 Aug
EPS$1.14
Beat 161.5%
Q1 20266 May
EPS$0.44
Beat 2.3%
Q4 202525 Feb
EPS$1.94
Beat 470.6%
Q3 20255 Nov
EPS$1.08
Beat 134.8%
Q2 20256 Aug
EPS$0.77
Beat 35.1%
Q1 20257 May
EPS$0.74
Beat 151.9%
Q4 202426 Feb
EPS$0.26
Miss 23.5%
Q3 20246 Nov
EPS$0.02
Miss 92.6%
Q2 202431 Jul
EPS$-0.55
Miss 329.2%
Q1 20248 May
EPS$0.46
Beat 170.6%
Q4 20231 Mar
EPS$0.76
Beat 230.4%
Q3 20231 Nov
EPS$0.98
Beat 263.0%
Q2 20232 Aug
EPS$0.02
Miss 92.3%
Q1 202326 Apr
EPS$0.42
Beat 82.6%
Q4 202228 Feb
EPS$0.25
Miss 39.0%
Q3 20229 Nov
EPS$2.80
Beat 1.8%
Q2 202227 Jul
EPS$0.05
Miss 96.6%
Q1 202227 Apr
EPS$0.35
Miss 20.4%
Q4 20219 Feb
EPS$0.55
Beat 34.1%
Q3 202127 Oct
EPS$0.90
Beat 109.3%
Q2 202128 Jul
EPS$0.90
Beat 210.3%
Q1 202128 Apr
EPS$0.84
Beat 8500.0%
Q4 20203 Feb
EPS$0.48
Beat 20.0%
Q3 202028 Oct
EPS$0.28
Miss 33.3%
Q2 202029 Jul
EPS$0.69
Beat 115.6%
Q1 202029 Apr
EPS$0.59
Beat 63.9%
Q4 20195 Feb
EPS$0.42
Miss 16.0%
Q3 201930 Oct
EPS$0.36
Miss 2.7%
Q2 201924 Jul
EPS$0.34
Miss 20.9%
Q1 20191 May
EPS$0.31
Miss 13.9%
Q4 20186 Feb
EPS$2.34
Beat 260.0%
Q3 201831 Oct
EPS$0.43
Miss 12.2%
Q2 201826 Jul
EPS$0.49
Miss 10.9%
Q1 201826 Apr
EPS$0.27
Miss 49.1%
Q4 20178 Feb
EPS$0.50
Beat 19.1%
Q3 201725 Oct
EPS$0.22
Miss 29.0%
Q2 201726 Jul
EPS$0.30
Beat 11.1%
Q1 201727 Apr
EPS$0.18
Miss 33.3%
Q4 20169 Feb
EPS$0.22
Beat 15.8%
Q3 201627 Oct
EPS$0.13
Miss 31.6%
Q2 201628 Jul
EPS$0.13
Beat 8.3%
Q1 201628 Apr
EPS$0.04
Miss 60.0%
Q4 20153 Feb
EPS$0.04
Beat 300.0%
Q3 201528 Oct
EPS$-0.04
Miss 33.3%
Q2 201529 Jul
EPS$-0.07
Miss 16.7%
Q1 20156 May
EPS$-0.09
Miss 12.5%
Q4 201418 Feb
EPS$-0.14
Beat 0.0%
Q3 201430 Oct
EPS$-0.19
Miss 26.7%
Q2 20146 Aug
EPS$-0.57
Miss 29.6%
Q1 20147 May
EPS$-0.62
Miss 17.0%
Q4 20136 Feb
EPS$-0.46
Miss 21.1%
Q3 201324 Oct
EPS$-0.44
Beat 44.3%
Q2 201325 Jul
EPS$-0.37
Beat 19.6%
Q1 201325 Apr
EPS$-0.38
Beat 0.0%
Q4 201212 Feb
EPS$-0.33
Beat 19.5%
Q3 201230 Oct
EPS$-0.37
Beat 5.1%
Q2 201231 Jul
EPS$-0.42
Beat 2.3%
Q1 201226 Apr
EPS$0.93
Beat 10.7%
Q4 20119 Feb
EPS$-0.45
Miss 15.4%
Q3 201127 Oct
EPS$-0.37
Miss 12.1%
Q2 201128 Jul
EPS$-0.31
Miss 10.7%
Q1 201128 Apr
EPS$-0.28
Beat 0.0%
Q4 201015 Feb
EPS$-0.25
Beat 10.7%
Q3 201021 Oct
EPS$-0.29
Miss 7.4%
Q2 201022 Jul
EPS$-0.28
Beat 0.0%
Q1 201021 Apr
EPS$-0.35
Miss 20.7%
Q4 200911 Feb
EPS$-0.35
Miss 6.1%
Q3 200927 Oct
EPS$-0.35
Miss 2.9%
Q2 200923 Jul
EPS$-0.35
Beat 0.0%
Q1 200922 Apr
EPS$-0.31
Beat 3.1%
Q4 200812 Feb
EPS$-0.26
Beat 27.8%
Q3 200823 Oct
EPS$-0.34
Beat 2.9%
Q2 200824 Jul
EPS$-0.44
Beat 10.2%
Q1 200821 Apr
EPS$-0.49
Miss 2.1%
Q4 200714 Feb
EPS$-0.54
Beat 1.8%
Q3 200725 Oct
EPS$-0.53
Beat 15.9%
Q2 200726 Jul
EPS$-0.75
Miss 10.3%
Q1 200726 Apr
EPS$-0.82
Miss 22.4%
Q4 20068 Feb
EPS$-0.63
Beat 1.6%
Q3 200626 Oct
EPS$-0.63
Beat 0.0%
Q2 200627 Jul
EPS$-0.70
Beat 6.7%
Q1 200627 Apr
EPS$-0.86
Miss 24.6%
Q4 20059 Feb
EPS$-0.79
Miss 12.9%
Q3 200527 Oct
EPS$-0.71
Miss 18.3%
Q2 200527 Jul
EPS$-0.60
Beat 1.6%
Q1 20054 May
EPS$-0.59
Miss 5.4%
Q4 200429 Mar
EPS$-0.55
Miss 61.8%
Q4 200416 Feb
EPS$-0.56
Miss 24.4%
Q1 200430 Jun
EPS$-0.91

Dividends

Dividend History

8 Sept 2015
Amount $0.2500
10 Jun 2015
Amount $0.2500
10 Mar 2015
Amount $0.2500
21 Nov 2014
Amount $0.2500
26 Aug 2014
Amount $0.2500

Stock Splits

Split History

3 Jun 2014Stock Split
Ratio1241:1000

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about INVA

Which members of Congress have traded INVA?
1 member of Congress has disclosed 2 trade in Innoviva, Inc. (INVA) under the STOCK Act: George Whitesides.
When was INVA most recently disclosed by Congress?
The most recent INVA disclosure was a sale by George Whitesides on 25 March 2025.
What is the total disclosed congressional trading volume for INVA?
Members of Congress have disclosed approximately $450K in INVA sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in INVA?
This INVA page updates as soon as new STOCK Act disclosures are filed for Innoviva, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.